Tempest Therapeutics, Inc. (TPST)

NASDAQ: TPST · IEX Real-Time Price · USD

1.700

-0.020 (-1.16%)

At close: Jul 26, 2024, 4:00 PM

1.709

+0.009 (0.53%)

After-hours: Jul 26, 2024, 7:02 PM EDT

Tempest Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	12.39	11.66	12.11	9.82	4.91	5.51
Research & Development	17.16	17.5	22.53	17.17	14.39	17.87
Operating Expenses	29.55	29.16	34.64	26.99	19.3	23.37
Operating Income	-29.55	-29.16	-34.64	-26.99	-19.3	-23.37
Interest Expense	-1.47	-1.45	-1.62	-1.28	-	-
Interest & Investment Income	1.26	1.12	0.55	-	0.09	0.26
Other Non Operating Income (Expenses)	-	-	-	-0.03	-	8.75
Pretax Income	-29.76	-29.49	-35.71	-28.3	-19.21	-14.36
Income Tax Expense	-	-	-	-	-	0
Net Income	-29.76	-29.49	-35.71	-28.3	-19.21	-14.37
Net Income to Common	-29.76	-29.49	-35.71	-28.3	-19.21	-14.37
Shares Outstanding (Basic)	18	15	12	4	0	1
Shares Outstanding (Diluted)	18	15	12	4	0	1
Shares Change (YoY)	32.85%	33.49%	204.70%	709.62%	-44.17%	-
EPS (Basic)	-1.70	-1.91	-3.09	-7.47	-41.03	-17.13
EPS (Diluted)	-1.70	-1.91	-3.09	-7.47	-41.03	-17.13
Free Cash Flow	-26.53	-27.53	-31.63	-26.09	-19.07	-22.92
Free Cash Flow Per Share	-1.51	-1.79	-2.74	-6.88	-40.73	-27.34
EBITDA	-29.21	-28.78	-34	-26.61	-18.96	-23.27
D&A For EBITDA	0.34	0.38	0.64	0.37	0.34	0.1
EBIT	-29.55	-29.16	-34.64	-26.99	-19.3	-23.37

Source: S&P Capital IQ. Standard template.